Tilray stock soars 10% after company tapped to provide medic

Tilray stock soars 10% after company tapped to provide medical cannabis in French study
CNBC
1/26/2021
Katie Tsai
Tilray's stock surged nearly 10% Tuesday after announcing that the French government tapped it to provide cannabis for medical experiments.
The French National Agency for the Safety of Medicines and Health Products will begin the 18- to 24-month study during the first quarter.
Tilray's products will treat patients with neuropathic pain, epilepsy and multiple sclerosis who aren't getting relief from existing treatments.
© Provided by CNBC
A worker inspects cannabis plants inside the grow room at the Aphria Inc. Diamond facility in Leamington, Ontario, Canada, on Wednesday, Jan. 13, 2021. Tilray Inc. and Aphria Inc. agreed to combine their operations, forming a new giant in the fast-growing cannabis industry.

Related Keywords

Portugal , Leamington , Ontario , Canada , Cantanhede , Coimbra , France , French , Canadian , Brendan Kennedy , Tilray Inc , Aphria Inc , Health Products , French National Agency , Chief Executive Brendan , போர்சுகல் , லீமிங்டன் , ஆஂடேரியொ , கனடா , கண்டணஹீதே , கோவைஂப , பிரான்ஸ் , பிரஞ்சு , கனடியன் , பிரெண்டன் கெந்நெடீ , அப்ரியா இன்க் , ஆரோக்கியம் ப்ராடக்ட்ஸ் , தலைமை நிர்வாகி பிரெண்டன் ,